Vaxart, Inc. grants equity awards to new CFO, Jeroen Grasman, including 1,000,000 stock options and 350,000 RSUs

From GlobeNewswire: 2025-05-20 17:00:00

Vaxart, Inc. announced equity awards for new CFO, Jeroen Grasman, including an option for 1,000,000 shares of common stock and a restricted stock unit award for 350,000 shares, granted under the 2024 Inducement Award Plan. These awards are part of the offer letter to Mr. Grasman and vest over time, in accordance with Nasdaq Listing Rule 5635(c)(4). Vaxart is a biotech company developing oral recombinant vaccines for various diseases, utilizing a unique pill delivery platform. Their current programs include vaccines for coronavirus, norovirus, influenza, and a therapeutic vaccine for HPV. Contact Vaxart Media and Investor Relations for more information.



Read more at GlobeNewswire: Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing